Service d'anesthésie réanimation, hôpital Pitié-Salpêtrière, Assistance publique-Hôpitaux de Paris, faculté de médecine Pierre-et-Marie-Curie, université Paris VI, 47-83, boulevard de l'Hôpital, 75651 Paris cedex 13, France.
The aim of our work was to present a review of technical features and complications of general anesthesia during robot-assisted laparoscopic radical prostatectomy (RALRP).
Data on RALRP and general anesthesia were explored on Medline using the following MeSH terms: radical prostatectomy; morbidity; anesthesia complications; laparoscopy; robotics; Trendeleburg. Publications were considered on the following criteria: methodology, relevance and date of publication.
There was no data of level of evidence 1 available. The first RALRP was reported in 2000. Technological innovation brought by the robot with its 3-D vision, the acquisition of degrees of mobility and a more ergonomic position for the surgeon, have led to a growing interest from new teams in the western world. However, the RALRP generates constraints for the anesthesia team who need to incorporate the rules of laparoscopy and the patient's specific installation to guarantee maximum safety. There are inherent complications with the installation of the patient himself in the Trendelenburg position (ocular, neurological, hemodynamic, respiratory) and respiratory complications related to the specific procedure in gaseous atmosphere due to pneumoperitoneum. One of the criteria of the quality of publications in the field of surgery is related to the objective evaluation of complications by appropriate scale systems and the complications of general anesthesia must also be absolutely recorded.
RALRP had deeply modified the anatomical landmarks of the surgical removal of prostate cancer. However, the perioperative environment has also been completely altered and the installation of RALRP in the daily routine of a service requires from the anesthesia team to adapt their behavior to this sophisticated surgical access.
Article in French.
Written by:
Chatti C, Corsia G, Yates DR, Vaessen C, Bitker MO, Coriat P, Rouprêt M. Are you the author?
Reference: Prog Urol. 2011 Nov;21(12):829-34.
doi: 10.1016/j.purol.2011.05.004
PubMed Abstract
PMID: 22035907
UroToday.com Prostate Cancer Section
